Ariad +4.3% AH, Daily Mail reports that pharmas are circling

|By:, SA News Editor

Ariad Pharmaceuticals (ARIA) shares spike 4.3% AH, after the Daily Mail floats a rumor that industry majors including Eli Lilly, GlaxoSmithKline, and Shire "have been sniffing around" ever since Iclusig was given the green light by the FDA.

The paper throws out the number $20/share as the price the potential suitors may be willing to pay.